Effect of N-nitrosodimethylamine on inducible nitric oxide synthase expression and production of nitric oxide by neutrophils and mononuclear cells: The role of JNK signalling pathway

APMIS

Volumn 119, Issue 7, 2011, Pages 431-441

  Ratajczak Wrona, Wioletta ^a   Jablonska, Ewa ^a   Garley, Marzena ^a   Jablonski, Jakub ^a   Radziwon, Piotr ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Regional Centre for Transfusion Medicine   (Poland)

Author keywords

Inducible nitric oxide synthase; JNK; N nitrosodimethylamine; Neutrophils; Nitric oxide; P38 MAPK; Peripheral blood mononuclear cells; Superoxide anion

Indexed keywords

3 NITROTYROSINE; DIMETHYLNITROSAMINE; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE; SYNAPTOPHYSIN;

ADULT; ARTICLE; CELL LEVEL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; NEUTROPHIL; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ADULT; CELLS, CULTURED; DIMETHYLNITROSAMINE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LEUKOCYTES, MONONUCLEAR; MAP KINASE SIGNALING SYSTEM; NEUTROPHILS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SUPEROXIDES; TYROSINE;

EID: 79958092574     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2011.02750.x     Document Type: Article

References (37)

1. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000;80:617-53.
2. Kroncke KD, Fehsel K, Kolb-Bachofen V. Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities. Biol Chem Hoppe Seyler 1995;376:327-43.
3. Lirk P, Hoffmann G, Rieder J. Inducible nitric oxide synthase - time for reappraisal. Curr Drug Targets Inflamm Allergy 2002;1:89-108.
4. Cedergren J, Follin P, Forslund T, Lindmark M, Sundqvist T, Skogh T. Inducible nitric oxide synthase (NOS II) is constitutive in human neutrophils. APMIS 2003;111:963-8.
5. Rostkowska K, Zwierz K, Rozanski A, Moniuszko-Jakoniuk J. Formation and metabolism of N-nitrosamines. Pol J Environ Studies 1998;7:321-5.
6. Jablonski J. N-nitrosodimethylamine - toxicologic significance. Postepy Hig Med Dosw 2001;55:317-37.
7. Holsapple MP, Bick PH, Duke SS. Effects of N-nitrosodimethylamine on cell mediated immunity. J Leukoc Biol 1985;37:367-81.
8. Ratajczak-Wrona W, Jablonska E, Jablonski J, Marcinczyk M. Induction of expression of iNOS by N-nitrosodimethylamine (NDMA) in human leukocytes. Immunopharmacol Immunotoxicol 2009;31:661-8.
9. MAPK and JNK/SAPK pathways are important for induction of nitric-oxide synthase by interleukin-1β in rat glomerular mesangial cells. J Biol Chem 1999;274:36200-26.
10. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Dérijard B, et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 1996;15:2760-70.
11. Rodriguez N, Lang R, Wantia N, Cirl V, Ertl T, Dürr S, et al. Induction of iNOS by Chlamydophila pneumoniae requires MyD88-dependent activation of JNK. J Leukoc Biol 2008;84:1585-93.
12. Korhonen R, Linker K, Pautz A, Förstermann U, Moilanen E, Kleinert H. Post-transcriptional regulation of human inducible nitric-oxide synthase expression by the Jun N-terminal Kinase. Mol Pharmacol 2007;71:1427-34.
13. Robbins RA, Grisham MB. Nitric oxide. Int J Biochem Cell Biol 1997;29:857-60.
14. Hanafy KA, Krumenacker JS, Murad F. NO, nitrotyrosine, and cyclic GMP in signal transduction. Med Sci Monit 2001;7:801-19.
15. Hughes MN. Relationships between nitric oxide, nitroxyl ion, nitrosonium cation and peroxynitrite. Biochim Biophys Acta 1999;1411:263-72.
16. Liu JS, Zhao ML, Brosnan CF, Lee SC. Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol 2001;158:2057-66.
17. Turko IV, Murad F. Protein nitration in cardiovascular diseases. Pharmacol Rev 2002;54:619-34.
18. Zeman K, Tchorzewski H, Majewska E. Simple and fast method of simultaneous isolation of lymphocytes and the polymorphonuclear cells from peripheral blood. Immunol Pol 1988;13:217-20.
19. - in aqueous and protein containing samples. Nitric Oxide 1999;3:225-34.
20. McCord JM, Fridovich I. The utility of superoxide dismutase in studying free radical reactions and radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen. J Biol Chem 1969;244:6056-63.
21. Jablonski J, Jablonska E, Moniuszko-Jakoniuk J. The influence of N-nitrosodimethylamine (NDMA) on the activity of anti-oxidant enzymes of neutrophil (PMN) of rats in research in vivo. Acta Toxicol 2003;1:21-6.
22. 2-terminal kinase inhibitor anthra(1, 9-cd)pyrazol-6(2H)-one reduces inducible nitric oxide synthase expression by destabilizing mRNA in activated macrophages. Mol Pharmacol 2003;64:308-15.
23. 2-terminal kinase and Janus kinase/signal transducer and activator of transcription pathways. J Endocrinol 2005;146:175-85.
24. Stempin CC, Garrido VV, Dulgerian LR, Cerban FM. Cruzipain and SP600125 induce p38 activation, alter NO/arginase balance and favor the survival of Trypanosoma cruzi in macrophages. Acta Trop 2008;106:119-27.
25. 2-terminal kinase pathway in human neutrophils. J Biol Chem 2002;277:40687-96.
26. Bodula A, Wdowczyk M, Adamiec R. The role of protein tyrosine phosphatase (PTP-1B) in insulin resistance. Postepy Hig Med Dosw 2005;59:203-7.
27. Mustelin T, Vang T, Bottini N. Protein tyrosine phosphatases and the immune response. Nat Rev Immunol 2005;5:43-57.
28. Guy GR, Philp R, Tan YH. Activation of protein kinases and the inactivation of protein phosphatase 2A in tumour necrosis factor and interleukin-1 signal-transduction pathways. Eur J Biochem 1995;229:503-11.
29. Thirunavukkarasu C, Watkins SC, Gandhi CR. Mechanisms of endotoxin-induced NO, IL-6, and TNF-alpha production in activated rat hepatic stellate cells: role of p38 MAPK. Hepatol 2006;44:389-98.
30. Devadas S, Zaritskaya L, Rhee SG, Oberley L, Williams MS. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and Fas ligand expression. J Exp Med 2002;195:59-70.
31. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol 2002;3:1129-34.
32. mapk in a mouse macrophage cell line. Am J Physiol Cell Physiol, 2001;280:C441-50.
33. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. PNAS 2001;98:13681-6.
34. Castro-Alcaraz S, Miskolci V, Kalasapudi B, Davidson D, Vancurova I. NF-κB regulation in human neutrophils by nuclear IκBα: correlation to apoptosis. J Immunol 2002;169:3947-53.
35. Nick JA, Avdi NJ, Young SK, Lehman LA, McDonald PP, Frasch C, et al. Selective activation and functional significance of p38α mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J Clin Invest 1999;103:851-8.
36. Schopfer FJ, Baker PR, Freeman BA. NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response? Trends Biochem Sci 2003;28:646-54.
37. Bian Ka, Gao Z, Weisbrodt N, Murad F. The nature of heme/iron-induced protein tyrosine nitration. PNAS 2003;100:5712-7.